Kentucky announced Wednesday that it will allocate tens of millions of dollars to support psychedelic drug research as part of its fight against opioid addiction.
At a Kentucky Opioid Advisory Committee press conference, state Attorney General Daniel Cameron detailed the committee’s plans to explore new treatments for individuals with opioid use disorder, a commitment that will include more than $40 million in psychedelic research.
“We can’t keep losing more than 2,000 KFCs [to addictions] Cameron said, It is also transmitted by an alpha anesthetic.
in the adThe committee said its proposal includes “investigating new therapies to reverse the chemical effects of opioid addiction, including opioid withdrawal.”
“Kentucky must overcome the opioid epidemic by all means necessary,” said Brian Hubbard, chairman and CEO of the Kentucky Opioid Control Advisory Committee (KYOAAC). “As we embark on the next phase in our fight against this crisis, we must explore any treatment option that shows breakthrough therapeutic potential. Our goal is to investigate the creation of a new standard for treatment of opioid dependence, so that we can finally end this cycle of pain in the Commonwealth.”
At Wednesday’s news conference, Hubbard said that “over the coming months, the commission will explore the possibility of allocating at least $42 million over the next six years to create public-private partnerships that can incubate, support and drive development.” Ibogaine throughout the FDA approval process. According to Alpha Dope.
The money will come from a $26 billion settlement reached last year between several state and local governments and some of the nation’s largest drug companies over their role in creating the opioid epidemic.
The Kentucky Opioid Advisory Committee was created last year and tasked with distributing more than $842 million awarded to the Commonwealth in last year’s settlements.
The committee is composed of nine voting members and two non-voting members and includes stakeholders from, among others, the prevention and treatment community, law enforcement, and victims of the opioid crisis. The UNHCR website shows.
The settlement resolved “more than 4,000 claims from state and local governments across the country,” According to Cameron’s website, It was “the second largest multi-state agreement in US history, second only to the Tobacco Master Settlement Agreement.”
Details of the interim settlement were initially announced on July 21, 2021, and after careful review, Attorney General Cameron signed the settlement on behalf of the Commonwealth. He was joined by a broad coalition of states and subdivisions to join two settlement agreements, one with opioid manufacturer Johnson & Johnson and the other with the drug’s three distributors: AmerisourceBergen, Cardinal Health and McKesson,” the site explains.
“The two settlement agreements require Distributors and J&J to pay billions of dollars to alleviate the opioid epidemic, totaling $26 billion over 18 years, while providing nearly $22.7 billion to combat opioids.”
Cameron Hubbard was appointed to oversee the committee last year.
At a press conference on Wednesday, Hubbard expressed the urgency to stem the tide of the pandemic.
“We must defeat the opioid epidemic by any humane means necessary,” Hubbard was quoted as saying. “Our history demands it.”
According to the Centers for Disease Control and PreventionThe number of drug overdose deaths increased by about 30% from 2019 to 2020 and has quintupled since 1999.
“Approximately 75% of the 91,799 drug overdose deaths in 2020 involved an opioid. From 2019 to 2020, there were significant changes in opioid-related death rates,” according to the CDC.
